We are live on
!
Find out more
PCM
Peregrine Capital Management Portfolio holdings
AUM
$3.08B
1-Year Est. Return
29.51%
This Fund
S&P 500
This Quarter
Est. Return
-6.78%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$4.22B
AUM Growth
-$771M
(-15%)
Cap. Flow
-$291M
Cap. Flow
% of AUM
-6.9%
Top 10 Holdings %
Top 10 Hldgs %
17.96%
Holding
353
New
17
Increased
57
Reduced
195
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$39.8M |
| 2 |
Cloudflare
NET
|
+$38.6M |
| 3 |
lululemon athletica
LULU
|
+$31.3M |
| 4 |
CrowdStrike
CRWD
|
+$26.2M |
| 5 |
First Interstate BancSystem
FIBK
|
+$11.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DOCU
DocuSign
DOCU
|
+$38.9M |
| 2 |
Teladoc Health
TDOC
|
+$33.6M |
| 3 |
Meta Platforms (Facebook)
META
|
+$31.8M |
| 4 |
Okta
OKTA
|
+$22.6M |
| 5 |
Lantheus
LNTH
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.26% |
| 2 | Healthcare | 18.03% |
| 3 | Financials | 14.95% |
| 4 | Consumer Discretionary | 12.53% |
| 5 | Industrials | 11.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
DoubleVerify
DV
$2.03B
| $8.77M | 0.21% |
348,559
+163,169
| +88% | +$4.25M |
|
202
Neurocrine Biosciences
NBIX
$16.5B
| $8.57M | 0.2% |
91,385
-6,553
| -7% | -$555K |
|
|
INN
203
Summit Hotel Properties
INN
$651M
| $8.54M | 0.2% |
857,324
-29,719
| -3% | -$292K |
|
204
Patterson-UTI
PTEN
$4.22B
| $8.52M | 0.2% |
+550,101
| New | +$6.94M |
|
205
Cadre Holdings
CDRE
$1.46B
| $8.49M | 0.2% |
345,757
-85,656
| -20% | -$1.93M |
|
206
Clarivate
CLVT
$1.22B
| $8.47M | 0.2% |
505,640
-27,535
| -5% | -$456K |
|
207
Vicor
VICR
$9.72B
| $8.42M | 0.2% |
+119,343
| New | +$10.7M |
|
208
VSE Corp
VSEC
$6.79B
| $8.3M | 0.2% |
180,063
-6,240
| -3% | -$311K |
|
209
FormFactor
FORM
$9.46B
| $8.28M | 0.2% |
196,945
-14,981
| -7% | -$624K |
|
|
OPLN
210
Openlane
OPLN
$4.48B
| $8.25M | 0.2% |
457,102
-33,488
| -7% | -$537K |
|
211
Urban Outfitters
URBN
$6.8B
| $8.24M | 0.2% |
328,322
-11,384
| -3% | -$311K |
|
|
CTT
212
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $8.21M | 0.19% |
1,001,719
+228,185
| +29% | +$1.87M |
|
213
Privia Health
PRVA
$2.81B
| $8.14M | 0.19% |
304,555
-22,457
| -7% | -$530K |
|
214
Cerus
CERS
$516M
| $8.14M | 0.19% |
1,482,436
+167,581
| +13% | +$928K |
|
215
PAR Technology
PAR
$721M
| $8.12M | 0.19% |
201,224
-14,675
| -7% | -$601K |
|
|
BPMC
216
DELISTED
Blueprint Medicines
BPMC
| $8.1M | 0.19% |
126,868
+3,199
| +3% | +$230K |
|
217
Cytokinetics
CYTK
$10.6B
| $8.08M | 0.19% |
219,540
+3,160
| +1% | +$112K |
|
|
FOLD
218
DELISTED
Amicus Therapeutics
FOLD
| $7.83M | 0.19% |
827,320
-47,451
| -5% | -$445K |
|
|
TUP
219
DELISTED
Tupperware Brands Corporation
TUP
| $7.83M | 0.19% |
402,476
-13,918
| -3% | -$237K |
|
220
Insmed
INSM
$29B
| $7.75M | 0.18% |
329,962
-23,665
| -7% | -$550K |
|
221
Scansource
SCSC
$1.05B
| $7.71M | 0.18% |
+221,534
| New | +$7.32M |
|
222
1-800-Flowers.com
FLWS
$259M
| $7.52M | 0.18% |
+589,357
| New | +$10.1M |
|
223
Sarepta Therapeutics
SRPT
$1.92B
| $7.52M | 0.18% |
+96,238
| New | +$7.37M |
|
|
PGTI
224
DELISTED
PGT, Inc.
PGTI
| $7.29M | 0.17% |
405,260
-29,540
| -7% | -$598K |
|
225
Stoneridge
SRI
$193M
| $7.26M | 0.17% |
349,582
-12,086
| -3% | -$222K |
|
Similar funds
CAM
MRCP
ECP
HCM
TCG
CLG
SAG
PC
Peregrine Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Peregrine Capital Management held 353 positions worth $4.22B, down 15% from $4.99B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Peregrine Capital Management withdrew a net $291M in Q1 2022, closing 19 positions and reducing 195 holdings. Its most notable exit was DocuSign, an estimated $38.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Peregrine Capital Management opened a new position in Abiomed Inc worth $42.8M.
- Peregrine Capital Management's largest Q1 2022 buy was Abiomed Inc: 129,135 shares worth $42.8M.
- Peregrine Capital Management added most to Callon Petroleum Company in Q1 2022, an estimated $9.01M increase.
- Peregrine Capital Management's biggest Q1 2022 reduction was Teladoc Health, cutting an estimated $33.6M.
- Peregrine Capital Management fully exited DocuSign in Q1 2022, selling an estimated $38.9M.
- Peregrine Capital Management's ten largest holdings make up 18% of its $4.22B portfolio in Q1 2022.
- Peregrine Capital Management opened 17 new positions and closed 19 in Q1 2022.
- Peregrine Capital Management's portfolio value fell 15% quarter-over-quarter to $4.22B.
Based on Peregrine Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.